In addition, the HGF-antagonist NK4 inhibits c-met signalling and angiogenesis in vitro [32] and reduces intratumoural microvessel density in a hepatocellular carcinoma xenograft model [54]. This evidence concerns the gene MET and hepatocellular carcinoma.